A study by the RIETE Group analyses how these drugs work in pregnant women and in people with cancer or cirrhosis, among others.

More than 400 experts met on April 3rd and 4th at the Palacio de Congresos of Córdoba for the 10th Venous Thromboembolism Multidisciplinary Forum.

In this edition, the meeting aims to emphasize the importance of the bleeding complications that occur during anticoagulation therapy, because they are a real and serious complication whose importance is often undervalued. Which patients are at the greatest risk of bleeding? Why do we continue anticoagulation for longer than the guidelines recommend? What do we do when a patient bleeds? and many other questions.

Other topics of interest were addressed, such as thrombosis in unusual locations (portal vein, cerebral venous sinuses and retinal veins) and incidental or subsegmental pulmonary embolism. Of course, we will continue to pursue the diagnosis, treatment, risk prediction and prevention of limb DVT and pulmonary embolism.

 

 

More news